statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC Research Report), Apollomics (AP...

Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif...

CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CalciMedica just reported results for the fourth quarter of 2023.
The post CALC Stock Earnings: CalciMedica Reported Results for Q4 2023...

CALC Stock Earnings: CalciMedica Reported Results for Q4 2023

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

CalciMedica presented preclinical data from studies of Auxora in acute AKI

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference CalciMedica Presents Data from Preclinical Studies of Auxora in...

CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference

Jonestrading assumed coverage on shares of CalciMedica (NASDAQ:CALC  Get Free Report) in a research note issued to investors on Friday, Benzinga reports. The firm set a buy&#8221...

CalciMedica (NASDAQ:CALC) Now Covered by Analysts at Jonestrading

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury CalciMedica Announces FDA Clearance of IND Application for Phase 2...

CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire LA...

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

CalciMedica files to sell 10.74M shares of common stock for holders

Equities researchers at HC Wainwright assumed coverage on shares of CalciMedica (NASDAQ:CALC  Get Free Report) in a report issued on Monday, Benzinga reports. The brokerage set a...

CalciMedica (NASDAQ:CALC) Now Covered by HC Wainwright

CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Watchers	3,452
52-Wk Low	$1.75
52-Wk High	$8.59

Volume	6,689.00
52-Wk High	$8.59
52-Wk Low	$1.75

CALC CalciMedica Inc

About

Feed

News

Fundamentals